NCT/Study#
NCT05183035 /
ITCC-101-APAL2020D
A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML
DISEASE GROUP:
Pediatric Oncology
current phase:
Phase III
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
